UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 526

Sortiert nach

Tumour budding: a promising parameter in colorectal cancer

British journal of cancer, 2012-05, Vol.106 (11), p.1713-1717

2012

Volltextzugriff (PDF)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

British journal of cancer, 2010-07, Vol.103 (3), p.382-390

2010

Volltextzugriff (PDF)

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer

British journal of cancer, 2015-06, Vol.112 (12), p.1944-1950

2015

Volltextzugriff (PDF)

Prognostic and predictive factors in colorectal cancer

Journal of clinical pathology, 2008-08, Vol.84 (994), p.403-569

2008

Volltextzugriff (PDF)

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients

British journal of cancer, 2014-02, Vol.110 (4), p.1008-1013

2014

Volltextzugriff (PDF)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer

British journal of cancer, 2014-06, Vol.110 (12), p.2914-2922

2014

Volltextzugriff (PDF)

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer

Gut, 2017-04, Vol.66 (4), p.692

2017

Volltextzugriff (PDF)

Tumour budding is a strong and independent prognostic factor in pancreatic cancer

European journal of cancer (1990), 2013-03, Vol.49 (5), p.1032-1039

2013

Volltextzugriff (PDF)

Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles

International journal of oncology, 2010-09, Vol.37 (3), p.707-718

2010

Volltextzugriff (PDF)

Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning

Modern pathology, 2020-05, Vol.33 (5), p.825-833

2020

Volltextzugriff (PDF)

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer

British journal of cancer, 2013-05, Vol.108 (10), p.2088-2096

2013

Volltextzugriff (PDF)

Potential clinical scenarios of tumour budding in colorectal cancer

Acta gastro-enterologica belgica, 2019-10, Vol.82 (4), p.515-518

2019

Volltextzugriff (PDF)

MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor

Prostate cancer and prostatic diseases, 2016-09, Vol.19 (3), p.242-247

2016

Volltextzugriff (PDF)

p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters

Annals of oncology, 2010-10, Vol.21 (10), p.1961-1966

2010

Volltextzugriff (PDF)

Immunophenotypic profile of tumor buds in breast cancer

Pathology, research and practice, 2018-01, Vol.214 (1), p.25-29

2018

Volltextzugriff (PDF)

CD8+ lymphocytes tumour-budding index: an independent prognostic factor representing a 'pro- anti-tumour' approach to tumour host interaction in colorectal cancer

British journal of cancer, 2009-10, Vol.101 (8), p.1382-1392

2009

Volltextzugriff (PDF)

Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer

Gut, 2008-10, Vol.57 (10), p.1413-1419

2008

Volltextzugriff (PDF)

Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning

Modern pathology, 2020-05, Vol.33 (5), p.981-981

2020

Volltextzugriff (PDF)

Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients

British journal of cancer, 2010-01, Vol.102 (1), p.151-161

2010

Volltextzugriff (PDF)

Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform

Immuno-oncology technology, 2021-06, Vol.10, p.100034, Article 100034

2021

Volltextzugriff (PDF)

Prognostic significance of the wnt signalling pathway molecules APC, β-catenin and E-cadherin in colorectal cancer-a tissue microarray-based analysis

Histopathology, 2007-03, Vol.50 (4), p.453-464

2007

Volltextzugriff (PDF)

A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy

British journal of cancer, 2007-03, Vol.96 (5), p.793-800

2007

Volltextzugriff (PDF)

New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma

Journal of clinical pathology, 2009-11, Vol.62 (11), p.986-997

2009

Volltextzugriff (PDF)

Loss of E-cadherin independently predicts the lymph node status in colorectal cancer

Pathology, 2011-02, Vol.43 (2), p.133-137

2011

Volltextzugriff (PDF)

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy

British journal of cancer, 2008-01, Vol.98 (2), p.450-456

2008

Volltextzugriff (PDF)

1 – 25 von 526

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(448)
Mit Volltextzugriff
(511)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Tumour budding: a promising parameter in colorectal cancer

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer

Prognostic and predictive factors in colorectal cancer

Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer

Tumour budding is a strong and independent prognostic factor in pancreatic cancer

Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles

Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning

Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer

Potential clinical scenarios of tumour budding in colorectal cancer

MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor

p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters

Immunophenotypic profile of tumor buds in breast cancer

CD8+ lymphocytes tumour-budding index: an independent prognostic factor representing a 'pro- anti-tumour' approach to tumour host interaction in colorectal cancer

Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer

Correction to: Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning

Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients

Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform

Prognostic significance of the wnt signalling pathway molecules APC, β-catenin and E-cadherin in colorectal cancer-a tissue microarray-based analysis

A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy

New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma

Loss of E-cadherin independently predicts the lymph node status in colorectal cancer

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy

Suchergebnisse filtern